Vimarsana
Biggest News Aggregation in the World

Page 2 - Nancy Simonian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nancy Simonian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nancy Simonian Today - Breaking & Trending Today

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript - Vimarsana News

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning and welcome to Syros Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors and Media section of Syros’ website at www.syros.com. Please be advised that today’s call is being recorded. […]

Source: yahoo.com
Syros Pharmaceuticals, Inc. Announces Chief Executive Officer Changes, Effective December 2, 2023 - Vimarsana News

Syros Pharmaceuticals, Inc. Announces Chief Executive Officer Changes, Effective December 2, 2023

Syros Pharmaceuticals announced the retirement as Chief Executive Officer of Nancy Simonian, M.D., and the appointment of Conley Chee, Syros? Chief Commercial Officer and Chief Business Officer , as...

Syros To Axe Around 35% Of Staff To Focus On Tamibarotene, Appoints Conley Chee As CEO; Stock Down - Vimarsana News

Syros To Axe Around 35% Of Staff To Focus On Tamibarotene, Appoints Conley Chee As CEO; Stock Down

Syros Pharmaceuticals (SYRS), a company focused on hematologic malignancies, said on Monday that it is cutting around 35 percent of its staff as part of its efforts to focus on late-stage development of tamibarotene in MDS and AML and ongoing pre-launch activities.

Syros Pharmaceuticals undergoes leadership shakeup, workforce reduction - Vimarsana News

Syros Pharmaceuticals undergoes leadership shakeup, workforce reduction

Syros Pharmaceuticals shares dropped on Monday after a series of shakeups at the biotech company. The firm is saying goodbye to its CEO, Nancy Simonian, who...

Syros Pharmaceuticals Shares Fall 18% on Staff Cuts, CEO Retirement - Vimarsana News

Syros Pharmaceuticals Shares Fall 18% on Staff Cuts, CEO Retirement

By Oyin Adeoyin Syros Pharmaceuticals shares fell after the company cut more than one- third of its staff and said its chief executive will resign. The stock...